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The primary progressive aphasias (PPA) are a heterogeneous group of language-led neurodegenerative
diseases resulting from large-scale brain network degeneration. White matter (WM) pathways bind
networks together, and might therefore hold information about PPA pathogenesis. Here we used diffu-
sion tensor imaging and tract-based spatial statistics to compare WM tract changes between PPA
syndromes and with respect to Alzheimer’s disease and healthy controls in 33 patients with PPA
(13 nonﬂuent/agrammatic PPA); 10 logopenic variant PPA; and 10 semantic variant PPA. Nonﬂuent/
agrammatic PPA was associated with predominantly left-sided and anterior tract alterations including
uncinate fasciculus (UF) and subcortical projections; semantic variant PPA with bilateral alterations in
inferior longitudinal fasciculus and UF; and logopenic variant PPA with bilateral but predominantly
left-sided alterations in inferior longitudinal fasciculus, UF, superior longitudinal fasciculus, and
subcortical projections. Tract alterations were more extensive than gray matter alterations, and the
extent of alteration across tracts and PPA syndromes varied between diffusivity metrics. These WM
signatures of PPA syndromes illustrate the selective vulnerability of brain language networks in these
diseases and might have some pathologic speciﬁcity.
 2013 Elsevier Inc. Open access under CC BY license.1. Introduction without agrammatism, associated with predominantly left-sidedThe primary progressive aphasias (PPA) or ‘language-led
dementias’ are important on clinical and neurobiological grounds
(Gorno-Tempini et al., 2011; Grossman, 2010; Rohrer et al., 2010c).
Clinically, PPA is associated with the selective but relentless erosion
of language functions; and neurobiologically PPA illustrates regional
vulnerability of brain language systems to neurodegenerative
pathologies that are collectively characterized by abnormal protein
accumulation. The spectrum of PPA is clinically, anatomically, and
pathologically heterogeneous (Grossman, 2010). The canonical PPA
syndromes comprise semantic variant PPA (sv-PPA), characterized
by impaired knowledge of the meaning of words and objects in
association with focal predominantly left anterior temporal lobe
atrophy; nonﬂuent/agrammatic variant PPA (nv-PPA), characterized
by speech production failure with apraxia of speech and/or agram-
matism, associated with predominantly left-sided peri-Sylvian
atrophy; and logopenic variant PPA (lv-PPA), characterized by pro-
longed word-ﬁnding pauses and impaired phonological memorye, UCL Institute of Neurology,
þ44 207 676 2066.
oney).
 license.temporo-parietal atrophy (Gorno-Tempini et al., 2011; Rohrer
et al., 2009, 2010b).
Despite the recent formulation of new consensus diagnostic
criteria for PPA (Gorno-Tempini et al., 2011), substantial nosological
difﬁculties remain (Knibb et al., 2006). These include the frequent
occurrence of overlap syndromes, clinicoanatomical convergence
between syndromic subtypes and pathological heterogeneity
(Rogalski et al., 2011a; Rohrer et al., 2008, 2011). A recent wealth of
genetic and neuropathological data has enabled certain clinical PPA
phenotypes to be correlated with particular pathological
substrates: for example, sv-PPA is predominantly associated with
TAR DNA-binding protein 43 (TDP-43) type C pathology and lv-PPA
with Alzheimer’s disease (AD) pathology (Grossman, 2010; Rohrer
et al., 2011; Whitwell and Josephs, 2011). However, despite these
advances, predicting tissue pathology or indeedmaking an accurate
clinical diagnosis remains challenging for the diseases in the PPA
spectrum. This is compounded by a paucity of robust in vivo
biomarkers to detect disease onset and track disease progression.
These issues in turn present challenges for planning future trials of
disease-modifying therapies in PPA: such trials are likely to target
speciﬁc pathologies and to seek to initiate treatments early in the
disease course to minimize cognitive decline.
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connectivity networks associated with neurodegenerative disease
syndromes (Greicius et al., 2004; Seeley et al., 2009) suggests
a potentially powerful framework for understanding the regionally-
speciﬁc but distributed effects of PPA diseases. White matter (WM)
tracts bind cortical hubs within neural networks, and WM tract
changes are therefore likely to hold important information about
brain network disintegration in neurodegenerative pathologies.
However, though substantial evidence has been amassed
concerning regional cortical proﬁles of PPA (Gorno-Tempini et al.,
2004; Josephs et al., 2006; Mummery et al., 2000; Pereira et al.,
2009; Rohrer et al., 2009, 2010b), relatively little information is
available concerning changes in WM tracts within brain language
networks produced by neurodegenerative disease (Agosta et al.,
2010; Whitwell et al., 2010; Zhang et al., 2009). Previous WM
tract studies in PPA (Acosta-Cabronero et al., 2011; Agosta et al.,
2010, 2011; Galantucci et al., 2011; Schwindt et al., 2011) have
shown considerable anatomic andmethodological variability. There
remain few detailed comparisons between PPA subtypes and other
neurodegenerative diseases, and between gray matter (GM) and
WM changes in these diseases. Besides facilitating diagnosis and
tracking of PPA (Larsson et al., 2004; Schmierer et al., 2007) iden-
tiﬁcation of WM tract signatures of PPA syndromes might improve
our understanding of the pathophysiology of network disintegra-
tion in these diseases and could yield important insights into the
molecular organization of vulnerable language networks (Raj et al.,
2012; Warren et al., 2012; Zhou et al., 2012).
Here we set out to identify proﬁles of white matter tract
degeneration in each of the canonical clinical subtypes of PPA using
diffusion tensor imaging (DTI) with several diffusivity metrics and
an anatomically unrestricted tract-based statistical approach. We
hypothesized that characteristic signatures of WM tract degenera-
tion underpin each PPA subtype within the distributed language
network.We further hypothesized that these signatures distinguish
PPA syndromes from each other and from other neurodegenerative
diseases, in line with a core role for speciﬁc network disintegration
in the pathogenesis of PPA.
2. Methods
2.1. Subjects
Consecutive patients fulﬁlling current consensus criteria
(Gorno-Tempini et al., 2011) for a diagnosis of PPA were recruited
from the Specialist Cognitive Disorders Clinic at the National
Hospital for Neurology and Neurosurgery. Subjects underwent
a structured clinical and neurolinguistic assessment and structural
magnetic resonance imaging (MRI) to exclude signiﬁcant WM
disease or other focal cerebral lesions. For purposes of syndrome
deﬁnition, a general neuropsychological assessment using stan-
dardized tests was performed. Behavioral tests are described in
more detail in the Supplementary data (see “Description of
behavioural tests”). Demographic and neuropsychological data
were analyzed statistically in STATA 10 (Statacorp) using Student
t test and Wilcoxin rank-sum tests of signiﬁcance. In addition,
cerebrospinal ﬂuid (CSF) data (if available) were analyzed to assess
the extent to which particular syndromes were likely to have
underlying AD (versus non-AD) pathology. Total CSF tau (a measure
of neuronal loss, as a nonspeciﬁc accompaniment of neuro-
degeneration) and CSF amyloid-beta1e42 (Aß1e42; a measure of
amyloid deposition speciﬁc for AD pathology) were measured
(Innotest platforms, Innogenetics, Ghent, Belgium). Local reference
ranges for tau and Aß1e42 were used to assess the likelihood
of underlying AD versus non-AD pathologies; cases deemed to
have probable underlying AD pathology had tau >307 pg/mL andAß1e42 <325 pg/mL (cutoffs derived from local data with 85%
sensitivity for AD).
Ethical approval for the study was obtained from the local
institutional ethics committee and all subjects gave written
informed consent to participate in accordance with the Declaration
of Helsinki.
2.2. MRI acquisition
Brain MRI data were acquired for all subjects on a Siemens Trio
3T MRI scanner using a 32-channel phased array head-coil
(Siemens, Erlangen, Germany). Two 64-direction DTI sequences
were acquired with a single shot, spin-echo echo planar imaging
sequence (ﬁeld of view: 240 mm; matrix: 96  96; yielding an
isotropic voxel size of 2.5  2.5  2.5 mm; 55 contiguous axial
slices; repetition time: 6800 ms; echo time: 91 ms; b value: 1000
s/mm2), augmented with parallel imaging acceleration to reduce
susceptibility artifact. Nine sequences without diffusion weighting
were acquired (b ¼ 0 s/mm2). A sagittal 3-D magnetization
prepared rapid gradient echo T1 weighted volumetric MRI (echo
time/repetition time/inversion time ¼ 2.9/2200/900 ms, dimen-
sions of 256  256  208, voxel size of 1.1  1.1  1.1 mm) and
a coronal ﬂuid-attenuated inversion recovery sequence were
acquired. For all subjects, volumetric MRI, DTI, and ﬂuid-attenuated
inversion recovery sequences were assessed visually in all planes to
ensure adequate coverage and to exclude artifacts, unexpected
pathology, or signiﬁcant motion.
2.3. Diffusion image analysis
Raw diffusion weighted images were afﬁne-aligned to the ﬁrst
corresponding b0 image using a linear image registration tool
(FLIRT v5.5) within the FMRIB Software Library (FSL v4.1.5) (Cook
et al., 2006; Smith et al., 2004). DTI volumes were then combined
for tensor ﬁtting using CAMINO and the tensor eigenvalues (l1, l2,
and l3; where axial diffusivity, AX ¼ l1), radial diffusivity
(RD ¼ (l2 þ l3)/2), trace diffusivity, (TR ¼ l1 þ l2 þ l3) and
fractional anisotropy (FA) were extracted at each voxel. After tensor
ﬁtting, images were processedwith the tract-based spatial statistics
pipeline (TBSS v1.1) (Smith et al., 2006). A general linear model was
created incorporating disease group membership as the factor of
interest and nuisance covariates of age, sex, disease duration (as a
measure of disease severity), and total intracranial volume, calcu-
lated by summing GM,WM, and CSF acquired from segmentation of
the structural images (using SPM8, as described below). The same
model was ﬁtted separately to FA, RD, AX, and TR and each PPA
subgroup was contrasted with the healthy and disease control
groups and with each of the other PPA subgroups. Statistical anal-
ysis was implemented using the permutation-based (nonpara-
metric) ‘randomize’ tool within FSL with 5000 permutations
generated for each test. A signiﬁcance threshold (p < 0.05) was
applied after correction for multiple comparisons using family-wise
error (FWE) correction with threshold-free cluster enhancement
(TFCE) (Smith and Nichols, 2009). Signiﬁcant results were projected
onto a study-speciﬁc mean brain registered to standard (Montreal
Neurological Institute; MNI) space. To provide accurate anatomic
localization a series of tract-speciﬁc masks were applied to the
signiﬁcant whole brain results. Masks reﬂected the anatomic
location of major white matter structures generated using a previ-
ously published probabilistic WM tract atlas (Mori et al., 2004).
A probability threshold of >20% was deemed acceptable in deﬁning
the boundaries for each mask. In total 14 masks were generated
which included right and left inferior longitudinal fasciculus (ILF),
superior longitudinal fasciculus (SLF), uncinate fasciculus (UF),
anterior thalamic radiation (ATR), cingulum bundle (CB),
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fslstats further information on signiﬁcance level and number of
signiﬁcant voxels was obtained from the already thresholded
signiﬁcant (FWE-corrected) results within each anatomic mask.
To compare the extent of tract involvement within each disease
group using different diffusivity metrics (FA, AX, RD, and TR), the
number of voxels within each tract identiﬁed as signiﬁcant at the
prescribed threshold using that metric was divided by the total
number of voxels within each atlas derived mask and expressed as
a percentage. We chose to express tract involvement predomi-
nantly using this threshold-dependent, extent-based measure
rather than (for example) a mean diffusivity value across the whole
tract for 2 reasons: ﬁrst, averaging diffusivity values over tract
masks would be strongly inﬂuenced by partial volume effects (e.g.,
inclusion of CSF in themask) and/or crossing ﬁbers; and second, the
extent of tract involvement gives an indication of the anatomic
distribution of change that is not captured using a mean diffusivity
value. By focusing on thresholded extent maps, we aimed to focus
more precisely on disease effects.
2.4. Gray matter analysis
Proﬁles of GM atrophy were derived using voxel-based
morphometry with the New Segment (Weiskopf et al., 2011) and
DARTEL (Ashburner, 2007) toolboxes of SPM8 (www.ﬁl.ion.ucl.ac.
uk/spm) under Matlab 7.0 (Mathworks, Sherborn, MA, USA).
Segmentation, normalization, modulation, and smoothing of GM
images were performed using default parameter settings (8 mm
smoothing). Final DARTEL transformations were combined with
afﬁne transformations to MNI space. Nonparametric permutationTable 1
Summary of group demographic, neuropsychological, and CSF data
n (female) nv-PPA lv-PPA
13 (10) 10 (5)
Mean SD Mean SD
Age 65.7 9.4 67.0
Disease duration (years) 3.3 1.2 4.0
Recognition Memory-Words (/50)a 40.5 8.9 29.9
MMSE (/30) 18.0 10.9 16.9
Recognition Memory-Faces (/50)c 36.7 5.8 29.8
BPVS (/150)d 120.6 41.0 87.4 4
Concrete synonyms (/25)b 18.3 4.6 17.8
Graded Naming Test (/30)e 10.8 10.6 4.4
Graded Arithmetic Test (/24)f 4.2 2.6 0.1
VOSP Object Decision (/20) 16.5 3.1 14.6
Stroop Color Naming (s)h 74.5 21.4 68.0 2
Word Repetition (/45)i 21.8 16.0 40.3
Sentence Repetition (/10)j 3.7 3.9 6.2
Receptive Grammar-PALPA 55 (/24) 16.1 7.4 11.6
Baxter Spelling Test (/30) 11.2 9.7 6.7
CSF n ¼ 7 n ¼ 9
CSF Total tau (pg/mL) 540 370 888 31
CSF ABeta1e42 384 148 256 12
Number with neuropsychological data: sv-PPA, n ¼ 9; nv-PPA, n ¼ 11; lv-PPA, n ¼ 10. Fu
data (see “Description of behavioural tests”).
Key: AD, Alzheimer’s disease; BPVS, British Picture Vocabulary Scale; CSF, cerebrospinal
non-ﬂuent/agrammatic PPA; PALPA, psycholinguistic assessment of language processing
visual object and space perception test.
a p < 0.05 nv-PPA versus AD.
b p < 0.05 control versus all disease groups p < 0.05.
c p < 0.05 nv-PPA versus lv-PPA and sv-PPA; p < 0.05 lv-PPA versus sv-PPA.
d p < 0.05 sv-PPA versus all groups; p < 0.05 lv-PPA versus nv-PPA and AD.
e p < 0.05 sv-PPA versus all groups; p < 0.05 lv-PPA versus AD.
f p < 0.05 lv-PPA versus all groups.
g p < 0.05 control versus nv-PPA and lv-PPA.
h p < 0.05 nv-PPA versus AD.
i p < 0.05 nv-PPA versus lv-PPA and sv-PPA.
j p< 0.05 sv-PPA versus nv-PPA and lv-PPA.testing was used to examine differences in regional GM volume
between groups and included age, sex, total intracranial volume
and disease duration as nuisance covariates. Maps of GM atrophy
were overlaid onto an MNI152 standard brain after FWE correction
(p < 0.05) with TFCE.
3. Results
3.1. Subject characteristics
Thirty-three consecutive patients with PPA (mean age 65.2  7.9
years; 24 female) were identiﬁed. Most patients were characterized
as having nv-PPA (n¼ 13), lv-PPA (n¼ 10), or sv-PPA (n¼ 10) in line
with current criteria (Gorno-Tempini et al., 2011). Twenty age and
sex comparable healthy control subjects also participated (mean
age 64.7  5.5 years; 12 female). Twenty age and sex comparable
patients with a diagnosis of AD were also included (mean age 62.8
 5.0 years; 11 female) to act as disease controls. Thirty of 33
subjects completed a detailed neuropsychological assessment; the
remaining 3 patients were unable to comply with behavioral
testing, or declined and their syndromes were deﬁned based on
bedside clinical assessment alone. In addition we identiﬁed an
additional 2 patients with a cognitive syndrome compatible with
Granulin-associated aphasia (mean age 61  14.1 years; 1 female;
disease duration 2.8  1.8 years) (Rohrer et al., 2010a) and were
subsequently conﬁrmed to have a proganulin (GRN)mutation (both
exon 2 c31fs). We did not include these subjects in this group study
because of the fact that this group has clinically distinct features
and are likely to have speciﬁc proﬁles ofWM change on amolecular
basis. Demographic and neuropsychological data for all subjects aresv-PPA AD Control
10 (7) 20 (11) 20 (12)
Mean SD Mean SD Mean SD
6.1 63.4 6.7 62.8 5.0 64.7 5.5
1.4 5.0 2.0 5.6 3.8 d d
9.1 32.0 8.0 30.1 6.1 47.1b 2.3
8.5 20.6 8.5 21.0 4.6 29.6b 0.5
7.4 31.7 7.8 33.7 6.0 41.8b 5.0
6.4 65.6 49.2 135.5 22.8 147.8b 1.5
5.6 14.3 6.3 d d 24.5b 0.7
4.3 1.6 4.3 13.4 8.7 26.8b 1.7
0.3 8.3 8.8 5.1 4.3 12.9g 4.4
6.2 14.6 4.3 15.7 2.5 18.0b 3.5
0.6 56.8 23.0 55.2 18.6 30.2b 3.8
5.1 43.9 1.4 d d 44.3g 1.0
3.1 9.6 0.7 d d 9.8g 0.6
6.0 21.1 3.0 d d 23.5b 0.7
5.9 14.0 10.4 d d 26.9g 1.3
n ¼ 5 n ¼ 10
8 350 131 770 355
2 669 156 240 64
rther background information about behavioral tests is provided in Supplementary
ﬂuid; lv-PPA, logopenic variant PPA; MMSE, Mini-Metal State Examination; nv-PPA,
in aphasia; PPA, primary progressive aphasia; sv-PPA, semantic variant PPA; VOSP,
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or sex between disease and control groups. Neuropsychological
proﬁles were in keeping with the clinical diagnosis in each group.
CSF data were available on 31 (56%) of all 53 affected individuals
(comprising 7 nv-PPA, 9 lv-PPA, 5 sv-PPA, and 10 AD). Two of 7
nv-PPA cases (29%) had CSF consistent with underlying non-AD
pathology and 8 of 9 lv-PPA cases (89%) had CSF consistent with
AD pathology. All sv-PPA cases had CSF consistent with non-AD
pathology. All clinically diagnosed AD cases had CSF consistent
with AD pathology.
3.2. PPA groups versus healthy controls and AD disease-controls
WM tract alterations were identiﬁed for each PPA syndromic
group compared with healthy control (Figs. 1, 2, and 3) and AD
disease-control (Fig. 4) groups. Maps of altered diffusivity for ADFig. 1. Patterns of decreased fractional anisotropy (FA) in primary progressive aphasia (PPA
(Montreal Neurological Institute coordinates shown on left) derived from the average FA skel
bar (bottom) codes signiﬁcance (family-wise error corrected p value). Abbreviations: lv-PPA
variant PPA.disease-controls compared with healthy controls are presented in
Supplementary Fig. 1. Individual tracts are listed and their
involvement in each PPA syndrome relative to healthy controls is
quantiﬁed in Table 2; quantitative data relative to the AD group are
presented in Supplementary Table 1. Here, we ﬁrst consider the
overall proﬁle of WM tract involvement in each syndrome, taking
all diffusivity metrics into account (differences in the pattern of
involvement across metrics are considered below).
Comparedwith healthy subjects, the nv-PPA group hadWM tract
degeneration in both cerebral hemispheres predominantly
involving the left anterior frontal lobe (UF) and subcortical
(ATR, CST) projections; in the comparison of nv-PPAwith AD, the AD
group showed more extensive posterior hemisphere WM tract
degeneration (splenium CC, fornix, right ILF, right SLF). The proﬁle of
WM tract degeneration was most marked in anterior-dorsal left UF
and anterior left ATR with less marked involvement of right) groups versus healthy control group. Results are overlaid on representative sections
eton. For coronal and axial sections, the right hemisphere is shown on the left. The color
, logopenic variant PPA; nv-PPA, nonﬂuent/agrammatic variant PPA; sv-PPA, semantic
Fig. 2. Patterns of increased axial and radial diffusivity in primary progressive aphasia (PPA) groups versus healthy control group. For each panel, the axial diffusivity (AX) map
(green) is displayed on the top and the radial diffusivity (RD) map (blue) on the bottom. Results are overlaid on representative sections (Montreal Neurological Institute coordinates
shown below) derived from the average fractional anisotropy skeleton. For coronal and axial sections, the right hemisphere is shown on the left. Color bars (bottom) code level of
signiﬁcance (family-wise error corrected p value). Abbreviations: lv-PPA, logopenic variant PPA; nv-PPA, nonﬂuent/agrammatic variant PPA; sv-PPA, semantic variant PPA.
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tract change in nv-PPA (based on the total number of signiﬁcant
voxels across all tracts) was detected using RD (5.6% of tracts
affected), followed by FA (5.1%), and AX (3.2%). Compared with
healthy subjects, the lv-PPA group had extensive WM tract alter-
ations within bilateral fronto-temporo-parietal regions, more
marked posteriorly and within the left hemisphere with involve-
ment of both dorsal and ventral WM tracts (ILF, UF, SLF, CB, ATR,
fornix) and also CC; when compared with the AD group, no signif-
icant WM tract differences were observed. The proﬁle of WM tract
degenerationwas most marked in left ILF, left CB, fornix, and left UF.
The greatest degree of WM tract change in lv-PPA was detected
using RD (10.6% of tracts affected), followed by FA (8.8%), and AX
(8.8%). Compared with healthy subjects and AD patients, the sv-PPA
group hadWM tract degeneration involving both hemispheres with
a particular emphasis on fronto-temporal (UF, ILF) WM tracts. Theproﬁle of WM tract degeneration was most signiﬁcant within
anterior-ventral ﬁbers of bilateral UF and ILF with less signiﬁcant
involvement of dorsal and posterior WM tracts. The greatest degree
of WM tract change in sv-PPA was detected using RD (8.5% of tracts
affected), followed by FA (7.7%), and AX (3.8%).3.3. Comparisons between PPA groups
WM tract differences between PPA syndromic groups were
also identiﬁed (Fig. 5); quantitative data are presented in
Supplementary Table 2.
sv-PPA was associated with greater alterations in bilateral ILF
and UF (left > right) relative to nv-PPA; and in bilateral ILF (left >
right) and left UF relative to lv-PPA. lv-PPA was associated with
more posterior bilateral WM tract alterations including ILF, SLF, UF,
Fig. 3. Patterns of increased trace diffusivity in primary progressive aphasia (PPA) groups versus healthy control group. Results are overlaid on representative sections (Montreal
Neurological Institute coordinates shown on left) derived from the average fractional anisotropy skeleton. For coronal and axial sections, the right hemisphere is shown on the left.
Color bars (bottom) code level of signiﬁcance (family-wise error corrected p value). Abbreviations: lv-PPA, logopenic variant PPA; nv-PPA, nonﬂuent/agrammatic variant PPA; sv-PPA,
semantic variant PPA; TR, trace diffusity.
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splenium of CC relative to sv-PPA.
3.4. Individual subject DTI data
In light of the wide variation of group-level values between DTI
metrics for SLF, a key language pathway (see Table 2), we also
examined individual subject FA and TR data within SLF (results
presented in Supplementary Fig. 2). The spread of individual values
was somewhat wider for nv-PPA than for other PPA groups, though
signiﬁcantly different with respect to the healthy control group.
3.5. Gray matter analysis
In the voxel-based morphometry analysis, each PPA syndromic
group showed the anticipated proﬁle of regional GM loss comparedwith the healthy control group (Fig. 6). sv-PPA was associated with
bilateral but predominantly left-sided atrophy of antero-inferior
temporal and orbitofrontal cortices. nv-PPA was associated with
atrophy of left inferior frontal and opercular cortex. lv-PPA was
associated with more extensive left hemispheric atrophy involving
inferior and posterior-superior temporal lobe, temporo-parietal and
temporo-occipital junctions. Regions of WM tract alteration closely
neighbored atrophic cortical regions within each syndrome (i.e., left
UF and left insular cortex in nv-PPA, left ILF and left temporo-
parietal cortex in lv-PPA, anterior ILF and anterior temporal
cortices in sv-PPA). However the tract alterations were spatially
more distributed, extending beyond the zones of GM loss. This
apparent disparity was most evident for lv-PPA, and less evident for
nv-PPA and sv-PPA. The extent of WM tract changes varied with
regard to the diffusivity metric used across all disease groups, with
RD being associated with more extensive changes than AX or FA.
Fig. 4. Comparison of white matter degeneration between primary progressive aphasia (PPA) groups and Alzheimer’s disease (AD) group. Top panel displays patterns of increased
axial diffusivity (AX) (top), radial diffusivity (RD) (middle), and trace diffusivity (TR) (bottom) in semantic variant PPA (sv-PPA) compared with AD. Bottom panel displays patterns of
increased AX in AD compared with nonﬂuent/agrammatic variant PPA (nv-PPA). Results are overlaid on representative sections derived from the average fractional anisotropy
skeleton. The right hemisphere is shown on the left. Color bars (bottom) code level of signiﬁcance (family-wise error corrected p value).
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We have identiﬁed signatures of WM tract degeneration across
the PPA spectrum in relation to healthy controls and other
neurodegenerative syndromes. WM tract differences also
emerged on direct group-wise comparisons of PPA syndromes,
suggesting relative speciﬁcity of proﬁles for particular syndromes
and pathologies. Broad anatomical proﬁles of WM tract degener-
ation were identiﬁed for each of the disease groups here. The
proﬁles of WM tract damage show some convergence with
previous studies of WM tract involvement in PPA (Acosta-
Cabronero et al., 2011; Agosta et al., 2010, 2011; Galantucci et al.,
2011; Schwindt et al., 2011; Whitwell et al., 2010) (see Table 3);
however, a number of additionally involved WM tracts were also
identiﬁed for each of the syndromic groups in the present study,
and there was substantial overlap between PPA syndromes. On
visual inspection, WM damage appeared more widespread
compared with areas of GM damage. These ﬁndings provide
further evidence that WM tract metrics constitute markers of
neural network disintegration across the PPA spectrum and might
be helpful in tracking disease development.The WM tract proﬁles delineated here help to deﬁne network-
level substrates for the PPA syndromes. These proﬁles align with
patterns of network breakdown previously identiﬁed in sv-PPA,
nv-PPA, and lv-PPA (Seeley et al., 2009) and with language path-
ways proposed in the healthy brain (Saur et al., 2008). Here, nv-PPA
was associated in particular with more marked involvement of
anterior and subcortical tracts and relative sparing of more inferior
temporal lobe tracts; this would be consistent with previous
evidence concerning the neuroanatomic substrates of articulatory,
phonemic, and grammar processing (Katanoda et al., 2001; Skosnik
et al., 2002). Previous studies have demonstrated prominent
involvement of left SLF in nv-PPA (Agosta et al., 2011; Galantucci
et al., 2011; Schwindt et al., 2011); though involvement of left SLF
was also demonstrated here, there was substantial variability in
signiﬁcance levels across DTI metrics (see Table 2) and a somewhat
wider spread of individual subject FA data within the SLF in nv-PPA
compared with other PPA groups (see Supplementary Fig. 2). The
voxel-wise group data (Figs. 1, 2, and 3) also demonstrate involve-
ment of the left SLF in the nv-PPA group, most prominently the
anterior/frontal ﬁbers; this is consistent with previous work
showing that ﬁber tracts with a more anterior distribution (such as
Table 2
White matter tract changes in PPA groups compared with healthy control group: quantitative data
Group Fractional anisotropy Axial diffusivity Radial diffusivity Trace diffusivity
Tract p Voxels % Tract p Voxels % Tract p Voxels % Tract p Voxels %
sv-PPA R UF 0.002 309 17.9 L UF 0.004 405 14.5 R UF 0.001 371 21.4 R UF 0.003 364 21.0
L UF 0.003 526 18.9 L ILF 0.004 1113 11.7 L UF 0.002 566 20.3 L UF 0.004 573 20.5
R CB 0.004 243 13.9 L ATR 0.01 308 2.7 R CB 0.006 205 11.7 L ILF 0.008 1508 15.9
L ILF 0.008 1265 13.3 R ILF 0.01 685 10.3 L ILF 0.006 1621 17.1 R ILF 0.010 1025 15.3
L ATR 0.008 133 1.2 R UF 0.02 257 14.8 L SLF 0.006 1286 9.3 L SLF 0.012 1200 8.7
CC 0.01 8694 9.6 CC 0.02 3268 3.6 R ILF 0.008 1077 16.1 L ATR 0.013 537 4.7
R ILF 0.01 767 11.5 R SLF 0.02 67 0.6 L ATR 0.01 584 5.1 R ATR 0.017 312 3.0
L CB 0.01 244 8.0 L SLF 0.02 542 3.9 CC 0.01 8139 9.0 CC 0.020 7578 8.3
L SLF 0.01 1229 8.9 R ATR 0.02 108 1.1 R ATR 0.01 378 3.7 Fornix 0.022 349 3.3
R SLF 0.02 853 7.7 L CST 0.03 196 2.7 L CST 0.01 221 3.0 R SLF 0.029 608 5.5
L CST 0.02 17 0.2 R CST 0.04 147 2.2 Fornix 0.01 330 3.1 R CB 0.031 83 4.7
Fornix 0.02 45 0.4 Fornix 0.04 12 0.1 R SLF 0.01 831 7.5 L CST 0.032 206 2.8
R ATR 0.03 36 0.4 d d d d L CB 0.02 338 11.1 L CB 0.037 202 6.6
nv-PPA L UF 0.005 334 12.0 L ATR 0.007 672 5.865 L ATR 0.007 672 5.87 L ATR 0.009 644 5.6
L CST 0.009 47 0.6 L CST 0.01 312 4.251 L UF 0.008 395 14.2 L UF 0.011 323 11.6
CC 0.01 7334 8.1 L UF 0.02 71 2.545 CC 0.01 7853 8.65 CC 0.011 7184 7.9
L CB 0.01 3 0.1 CC 0.02 4164 4.585 R ATR 0.01 406 3.96 R ATR 0.012 300 2.9
R CST 0.01 19 0.3 L SLF 0.02 15 0.109 L CST 0.01 49 0.67 R CST 0.016 106 1.6
Fornix 0.01 33 0.3 R CST 0.02 267 3.979 R UF 0.01 134 7.74 R UF 0.017 111 6.4
L ATR 0.01 618 5.4 R UF 0.03 66 3.813 R SLF 0.01 16 0.14 Fornix 0.021 20 0.2
R ATR 0.01 288 2.8 R ATR 0.03 111 1.083 Fornix 0.02 33 0.31 L CB 0.024 18 0.6
R UF 0.02 90 5.2 Fornix 0.04 10 0.095 R CST 0.02 16 0.24 R CB 0.025 1 0.1
R SLF 0.02 17 0.2 L CB 0.04 7 0.23 L SLF 0.02 752 5.44 R SLF 0.032 28 0.3
R ILF 0.02 15 0.2 R SLF 0.05 210 0.135 R CB 0.02 99 1.20 L CST 0.033 40 0.5
L ILF 0.03 78 0.8 d d d d L CB 0.03 21 0.53 L SLF 0.034 77 0.6
L SLF 0.03 595 4.3 d d d d L ILF 0.04 98 1.03 d d d d
R CB 0.04 15 0.9 d d d d R ILF 0.04 27 0.40 d d d d
lv-PPA Fornix 0.006 41 0.388 L ATR 0.004 724 6.319 L ILF 0.003 1888 19.89 L CB 0.002 230 7.6
L ILF 0.009 1628 17.15 L SLF 0.004 1303 9.432 R ILF 0.004 1403 21 L ILF 0.002 1848 19.5
L CB 0.009 392 12.9 L ILF 0.004 1381 14.55 CC 0.004 11278 12.42 CC 0.004 12320 13.6
L UF 0.009 459 16.45 CC 0.005 9711 10.69 L UF 0.005 394 14.12 R ILF 0.004 1349 20.2
CC 0.010 9711 10.69 L CB 0.005 172 5.66 L CB 0.005 374 12.31 R UF 0.005 241 13.9
L ATR 0.012 526 4.591 L CST 0.006 276 3.76 Fornix 0.005 45 0.426 L SLF 0.005 1577 11.4
L SLF 0.012 788 5.704 R ILF 0.006 994 14.88 L SLF 0.006 1470 10.64 L UF 0.005 366 13.1
R CB 0.013 245 14 R SLF 0.006 913 8.227 R ATR 0.006 351 3.423 L ATR 0.005 728 6.4
R UF 0.014 145 8.377 R CST 0.007 190 2.831 R UF 0.006 237 13.69 Fornix 0.007 50 0.5
R ILF 0.015 1085 16.24 R UF 0.007 233 13.46 L ATR 0.007 711 6.206 R SLF 0.008 1012 9.1
L CST 0.019 223 3.038 L UF 0.009 262 9.391 R CB 0.008 237 13.54 R ATR 0.008 364 3.6
R ATR 0.019 300 2.926 R ATR 0.011 281 2.741 R SLF 0.010 979 8.821 R CB 0.009 41 2.3
R CST 0.020 284 4.232 Fornix 0.019 9 0.085 L CST 0.013 253 3.447 R CST 0.010 209 3.1
R SLF 0.032 719 6.479 R CB 0.022 17 0.971 R CST 0.015 233 3.472 L CST 0.011 192 2.6
% indicates percentage of affected voxels within each tract. All results are FWE corrected p < 0.05 and ordered by p value. Bold indicates a signiﬁcance level of p < 0.01.
Key: ATR, anterior thalamic radiation; CB, cingulum bundle; CC, corpus callosum; CST, corticospinal tract; ILF, inferior longitudinal fasciculus; L, left; lv-PPA, logopenic variant
primary progressive aphasia; nv-PPA, nonﬂuent/agrammatic primary progressive aphasia; PPA, primary progressive aphasia; R, right; SLF, superior longitudinal fasciculus;
sv-PPA, semantic variant primary progressive aphasia; UF, uncinate fasciculus.
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(Galantucci et al., 2011). This proﬁle also provides a substrate for
executive dysfunction in the present and previous nv-PPA cohorts
(Rohrer et al., 2010b). sv-PPA here was associated in particular with
involvement of ILF and UF: these tracts could support the putative
anterior temporaleinferior frontal network mediating semantic
and evaluative processing of words and nonverbal objects (Awad
et al., 2007; Parker et al., 2005; Scott et al., 2000). lv-PPA was
associated with involvement of both dorsally-directed (SLF, CB) and
ventrally-directed (ILF) tracts, prominently including more poste-
rior temporo-parietal projections and similar to the pattern seen in
typical AD (Acosta-Cabronero et al., 2011); these widely distributed
tracts are likely to support a distributed network that in the
dominant hemisphere mediates phonological working memory
and praxis and other parietal functions (Awad et al., 2007; Simon
et al., 2002) and which has been previously implicated in the lv-
PPA syndrome (Gorno-Tempini et al., 2011; Rohrer et al., 2010b).
Though ILF involvement has been inconsistently reported in lv-PPA,
identiﬁcation of ILF in the lv-PPA group here is consistent with the
known engagement of the ventral language network in lexical
retrieval (Wong et al., 2011) and with previous studies of lv-PPAlinking lexical retrieval deﬁcits with more ventral GM atrophy
(Wilson et al., 2010). Despite their distinct clinical phenotypes there
was no signiﬁcant difference in WM tract involvement when the
lv-PPA and AD groups were directly compared; this suggests at least
partial overlap of WM tract degeneration in these syndromes, in
keeping with a common underlying disease pathology.
It is noteworthy that, for each of the PPA syndromes, WM tract
alterations occurred in proximity to regions of GM atrophy but also
extended more widely within each cerebral hemisphere (see
Fig. 6). Though caution is needed in comparing different neuro-
imaging modalities and in calibrating for the effects of local
atrophy on DTI metrics, it is unlikely that this disparity is attrib-
utable simply to technical factors: the WM changes delineated
were based on robust methodologies, for example the use of
permutation testing which does not assume normality (Nichols
and Holmes, 2002) and TFCE correction which is robust to non-
stationarity (Smith and Nichols, 2009). WM changes more exten-
sive than GM atrophy have been documented in previous WM
tract studies of PPA syndromes, albeit inconsistently between
studies (Acosta-Cabronero et al., 2011; Agosta et al., 2010, 2011;
Galantucci et al., 2011; Schwindt et al., 2011); this inconsistency
Fig. 5. Comparison of white matter (WM) tract degeneration between primary progressive aphasia (PPA) syndromic groups. Each tile shows signiﬁcant WM tract (family-wise error
corrected p < 0.05) differences between groups as measured by increased axial diffusivity (AX) and radial diffusivity (RD). The right hemisphere is shown on the left. Montreal
Neurological Institute coordinates are indicated below. Color bars (bottom) code level of signiﬁcance (family-wise error corrected p value). Abbreviations: L, left; lv-PPA, logopenic
variant PPA; nv-PPA, nonﬂuent/agrammatic variant PPA; sv-PPA, semantic variant PPA.
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and small patient cohorts. Moreover, in the present study, the
apparent disparity in the distribution of GM and WM changes
varied between PPA syndromes. One potential neurobiological
explanation for these ﬁndings would hold that WM tract damage
leads GM atrophy, at least in a proportion of PPA cases; and
further, that this tract vulnerability might be more marked in
certain PPA syndromes. A key pathophysiologic role of early WM
alterations is suggested by previous neuroimaging evidence in
asymptomatic mutation carriers (Borroni et al., 2008; Ringman
et al., 2007) and histopathologic evidence of extensive WM
pathology in frontotemporal lobar degeneration (FTLD) (Hiji et al.,
2008; Neumann et al., 2007). To evaluate this issue fully would
require a detailed longitudinal analysis of PPA syndromes, in order
to establish the temporal evolution of regional GM atrophy in
relation to WM tract disintegration.Though the role of particular diffusivity metrics in deﬁning
neurodegenerative pathologies remains controversial we have repli-
cated ﬁndings from a number of other studies (Acosta-Cabronero
et al., 2010; Agosta et al., 2011); see Table 3). Together this evidence
suggests that diffusivity metrics might vary in their potential to track
WM disintegration in different PPA syndromes. For example in this
study, across all groups, RD seemed to show the most widespread
proﬁle of WM change, and AX showed the least extensive change.
These ﬁndings are in keeping with previous evidence in PPA
(Galantucci et al., 2011; Schwindt et al., 2011). Tracts with the most
marked involvement on voxel-wise analysis (e.g., UF and ILF in
sv-PPA; see Table 2) tended to show broadly similar patterns of
involvement across diffusivity metrics. This suggests that the sensi-
tivityofmetrics for detectingWMchangemight relate to theextent of
tract damage, or that particular metrics (e.g., RD; see Table 2) might
detect change earlier or might be intrinsically more sensitive to
Fig. 6. Maps of gray matter (GM) atrophy (blue-green) and reduced white matter fractional anisotropy (FA) (orange-yellow) in primary progressive aphasia (PPA) syndromic groups
compared with healthy controls overlaid on a MNI152 template brain. GM and FA maps are thresholded at p < 0.05 after family-wise error correction with threshold-free cluster
enhancement. Montreal Neurological Institute coordinates are displayed. Color bars (bottom) code family-wise error corrected p values (blue-green) for GM atrophy and FA change
(red-yellow). Abbreviations: lv-PPA, logopenic variant PPA; nv-PPA, nonﬂuent/agrammatic variant PPA; R, right; sv-PPA, semantic variant PPA.
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pathology, because AX revealedmore extensive damage in the lv-PPA
and AD disease control groups (see Supplementary Fig. 1) compared
with nv-PPA or sv-PPA subtypes in this and previous studies
(Galantucci et al., 2011; Josephs et al., 2006; Rohrer et al., 2011).Wedo
not suggest that changes in any 1 diffusivity metric are intrinsically
speciﬁc for a particular pathology, but rather, that some metrics or
combinations of metrics might offer greater sensitivity in the detec-
tion of disease, which might in turn depend on how a particular
pathological protein damages a tract (Acosta-Cabronero et al., 2010;
Song et al., 2002). Again, these preliminary observations require
substantiation in longitudinal studies with head-to-head compari-
sons of candidate diffusivity metrics and pathologic correlation.
The WM tract signatures here were identiﬁed at the level of
large-scale networks; no single tract showed speciﬁcity for
a particular syndrome (nor by inference, for a particular pathology).
Comparing tract signatures across disease groups (Figs. 1, 2, and 3),
sv-PPAwas associated with predominant ventral tract involvement,
nv-PPA with more anterior-dorsal tract involvement, and lv-PPA
with more widespread tract changes. These WM tract proﬁles
accord with a recent macroanatomical classiﬁcation scheme
proposed for pathologies in the FTLD spectrum, based on proﬁles of
gray matter loss (Rohrer et al., 2011) and further suggest that
disease speciﬁcity might lie in the pattern of large-scale networkbreakdown. This study corroborates previous work suggesting that
the overall proﬁle of tract involvement might signal particular
pathologies. For example, the fornix and CB were here most
markedly involved in lv-PPA; these structures have been identiﬁed
as potentially useful anatomic biomarkers in the detection of AD
pathology, which underpins a high proportion of lv-PPA cases
(Huang et al., 2012; Oishi et al., 2012). Other tracts (for example, UF)
were involved across syndromes; such tracts could potentially play
a critical role in the diffusive spread of pathogenic proteins, which
might constitute a common mechanism of network disintegration
in neurodegenerative diseases (Raj et al., 2012; Warren et al., 2012;
Zhou et al., 2012).
This study has several limitations and highlights directions for
future work. Patient numbers were relatively small, assessments
were exclusively cross-sectional, and histopathologic conﬁrmation
was not obtained. A more complete understanding of the WM tract
correlates of the PPA syndromes will require larger disease cohorts
followed longitudinally. This is particularly pertinent given the
propensity of PPA syndromes to transform and converge over time
(Rogalski et al., 2011b); this transformation might depend on tract
alterations. A further important objective of future longitudinal
studies (particularly targeting genetic cases) will be to relate
earliest tract alterations to the onset and progression of neuronal
loss and clinical disease; this in turnwill require detailed behavioral
Table 3
Comparison of fractional anisotropy changes in DTI studies of PPA
Report Subjects Tract selection Dir Statistical
method
Software UF ILF SLF Other
NV LV SV NV LV SV NV LV SV NV LV SV
Agosta et al., 2010 SV ¼ 5; control ¼ 8 ROI (L ILF/L SLF/L
UF/CC)
55 Linear mixed
effects model
In-house nt nt L nt nt nsr nt nt La nt nt CCb
Whitwell et al., 2010 NV ¼ 7; SV ¼ 4; control ¼ 19 ROI; n ¼ 16 21 ANCOVA DTI Studio nsr nt nsr nsr nt Lc Rd nt nsr nt nt nt
Galantucci et al., 2011 NV ¼ 9; LV ¼ 9; SV ¼ 9; control ¼ 21 ROI (ILF/UF/SLF) 64 ANCOVA PROBTRACKX nsr nsr B nsr nsr Be L Lf Lg nt nt nt
Acosta-Cabronero
et al., 2011
SV ¼ 10; control ¼ 21 Whole brain 63 Nonparametric
permutation test
FDT/TBSS/
Tractography
nt nt nsr nt nt Lh nt nt nsr nt nt nt
Agosta et al., 2011 NV ¼ 9; LV ¼ 4; SV ¼ 7; control ¼ 27 Whole brain 32 Nonparametric
permutation test
FDT/TBSS L nsr B Li nsr Li L nsr nsr B CB, CC, FO FO CC, L CB, FO
Schwindt et al., 2011 SV ¼ 9; NV ¼ 9; control ¼ 16 Whole brain 23 Nonparametric
permutation test
FDT/TBSS L nt B L nt B nsr nt B nt nt L ATR, B FM, CC
Present study NV ¼ 13; LV ¼ 10; SV ¼ 10; AD ¼ 20;
control ¼ 20
Whole brain 64 Nonparametric
permutation test
CAMINO/TBSS L L B nsr L L nsr nsr nsr L CST L CB, FO L ATR, R CB
Results reported reﬂect most statistically robust ﬁndings (for present study, only signiﬁcance values p < 0.01 are included here; see also Table 2).
Key: AD, Alzheimer’s disease; ANCOVA, analysis of covariance; ATR, anterior thalamic radiation; B, bilateral; CB, cingulum bundle; CC, corpus callosum; CST, corticospinal tract; Dir, number of diffusion gradient directions used in
DTI acquisition; DTI, diffusion tensor imaging; FDT, FMRIB diffusion toolbox; FM, forceps major; FO, fornix; ILF, inferior longitudinal fasciculus; L, left; LV, logopenic variant PPA; nsr, no signiﬁcant result found; nt, data not
reported/tested; NV, nonﬂuent/agrammatic PPA; PPA, primary progressive aphasia; R, right; ROI, region of interest; SLF, superior longitudinal fasciculus; SV, semantic variant; TBSS, tract based spatial statistics; UF, uncinate
fasciculus.
a Arcuate and frontoparietal SLF.
b Genu.
c Posterior ILF.
d Anterior SLF.
e Bilateral anterior ILF and left medial ILF.
f SLF temporoparietal ﬁbers.
g Arcuate and SLF temporoparietal.
h Results reported based on authors’ ﬁgures.
i Inferior fronto-occipital fasciculus.
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C.J. Mahoney et al. / Neurobiology of Aging 34 (2013) 1687e16991698correlation. To establish their speciﬁcity for proteinopathies and
syndromes, in vivo tractographic proﬁles will ultimately need
histopathologic correlation. From a clinical perspective, there is
a need to establish the utility of particular diffusivity metrics as
biomarkers and the validity and limitations of group-level patterns
in classifying individual patients within each group (Dickerson
et al., 2008). Larger patient cohorts might help offset overlap
between PPA syndromes, however additional metrics derived from
other modalities (e.g., functional MRI) might be needed to further
reﬁne distributed structural tractographic proﬁles and to identify
tracts that are core to the development of each syndrome. Technical
limitations of this work include the use of a study-speciﬁc WM
skeleton under TBSS (restricting statistical analysis to the center of
each tract), and the use of masks (which are somewhat arbitrary
and might not capture the entire tract), particularly in areas of
crossing ﬁbers (Jbabdi et al., 2010). A further crucial issue which
was not directly addressed here is the relation between tract
degeneration and GM atrophy. Taking these caveats into account,
the present ﬁndings support the concept of differentially vulnerable
neuronal networks in particular PPA syndromes and proteino-
pathies. DTI metrics might furnish novel markers of brain network
breakdown in these diseases; more fundamentally, the tracto-
graphic delineation of PPA syndromes might contribute new
information about the pathophysiology of language network
breakdown and underlying molecular architecture.
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